Stocks and Investing
Stocks and Investing
Fri, May 31, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, May 30, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Ha Initiated (ALHC) at Buy and Held Target at $10 on, May 30th, 2024
Michael Ha of Baird, Initiated "Alignment Healthcare, Inc." (ALHC) at Buy and Held Target at $10 on, May 30th, 2024.
Michael has made no other calls on ALHC in the last 4 months.
There are 5 other peers that have a rating on ALHC. Out of the 5 peers that are also analyzing ALHC, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $7 on, Friday, May 3rd, 2024
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $8.5 on, Wednesday, February 28th, 2024
These are the ratings of the 3 analyists that currently disagree with Michael
- Jessica Tassan of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $8 on, Wednesday, May 8th, 2024
- Craig Jones of "Stifel" Maintained at Strong Buy with Decreased Target to $9 on, Tuesday, April 23rd, 2024
- Andrew Mok of "Barclays" Initiated at Sell and Held Target at $4.5 on, Wednesday, March 6th, 2024
Contributing Sources